Only Andersen et al. [22] reported higher rates of BRAF mutation among patients from the bad prognosis ICC subtype, and only Bao et al. [25] reported higher rates of ARID1A mutation among patients from the good prognosis ICC subtype. The gene discussed is ARID1A; the disease is intrahepatic cholangiocarcinoma.